Heart Failure Clinics

Article	Citations
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure	56
Unusual Forms of Pulmonary Hypertension	36
Tafamidis in the Treatment of ATTR-related Cardiomyopathy	29
Contents	26
Treatment of Advanced Heart Failure—Focus on Transplantation and Durable Mechanical Circulatory Support	26
Changing Landscape of Heart Failure Imaging	24
Forthcoming Issues	23
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging	20
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia	20
Preload Reduction Therapies in Heart Failure	19
Understanding Myocardial Metabolism in the Context of Cardio-Oncology	19
When all Else Fails, Try This	19
Therapy-Related Clonal Hematopoiesis	19
Genetics of High-Altitude Pulmonary Edema	18
Mitral Regurgitation	18
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine	18
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now	17
Arrhythmias in Adult Congenital Heart Disease Heart Failure	16
Contributors	16
Contributors	15
Specific Therapy in Transthyretin Amyloid Cardiomyopathy	13
Contributors	13
Copyright	13
Myocardial Dysfunction in Patients with Cancer	12
Contributors	12

Emerging Roles for Artificial Intelligence in Heart Failure Imaging	12
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure	12
What Is New in Risk Assessment in Nuclear Cardiology?	11
Arrythmia-Mediated Valvular Heart Disease	11
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure	11
Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy	10
Coronary Angiography in the Evaluation of Systolic Heart Failure	10
Guide to Temporary Mechanical Support in Cardiogenic Shock	10
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis	10
Heart Failure Clinics	10
Advanced Heart Failure in a Special Population	10
Noncoding RNAs in Pulmonary Arterial Hypertension	9
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging	9
Cardiac Contractility Modulation	9
SGLT2 Inhibitors in Heart Failure	9
Cardiac Amyloidosis	9
Application of 3D Printing Technology in Heart Failure	9
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population	9
Obtaining a Coronary Artery Calcium Score with Myocardial Perfusion Imaging	9
Contributors	8
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease	8
Contents	8
Copyright	8
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis	8
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes	7
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study	7
Contents	7
Echocardiography in Advanced Heart Failure for Diagnosis, Management, and Prognosis	7
Disease-modifier Drugs in Patients with Advanced Heart Failure	7
Preface	7
SGLT2 Inhibitors in Type 2 Diabetes Mellitus	6
Copyright	6
Contents	6
Inotropes in Patients with Advanced Heart Failure	6
Advanced Heart Failure in Special Population	6
Aortic Valvular Stenosis and Heart Failure	6
Advanced Heart Failure: From Pathophysiology to Clinical Management	6
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors	6
Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification	6
Remote Monitoring Devices and Heart Failure	5
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure	5
Exercise Testing in Pulmonary Hypertension and Heart Failure	5
Adults with Congenital Heart Disease and Transplant	5
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy	5
Contents	5
Clinical Practice Guidelines in Cardio-Oncology	4
SGLT2 Inhibitors and Peripheral Vascular Events	4
The Risk of Sudden Unexpected Cardiac Death in Children	4
Clinical Use of Biomarkers in Cardiac Amyloidosis	4
Contributors	4

The Role of Medical Therapy in Hypertrophic Cardiomyopathy	4
Novel Non-pharmacological Approaches to Heart Failure	4
Pathophysiology of Cardiac Amyloidosis	4
Coronary Microvascular Dysfunction	3
Pulmonary Hypertension in Adult Congenital Heart Disease–Related Heart Failure	3
Contributors	3
Clinical Value of Positron Emission Tomography Myocardial Perfusion Imaging and Blood Flow Quantification	3
Contributors	3
Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?	3
Copyright	3
Latest Updates in Heart Failure Imaging	3
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease	3
Forthcoming Issues	3
Advances in the Therapy of Light Chain Cardiac Amyloidosis	3
Epidemiology, Pathogenesis, and Clinical Course of Takotsubo Syndrome	3
Mechanical Circulatory Support in COVID-19	2
The Heart Muscle and Valve Involvement in Marfan Syndrome, Loeys-Dietz Syndromes, and Collagenopathies	2
Multimodality Imaging in the Evaluation of Hypertrophic Cardiomyopathy	2
Adult Congenital Heart Disease	2
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk	2
Contents	2
Contents	2
Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension	2
Forthcoming Issues	2
Changing Landscape of Heart Failure Imaging	2
Forthcoming Issues	2
Heart Failure Staging and Indications for Advanced Therapies in Adults with Congenital Heart Disease	2
Contents	2
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination	2
Clinical and Molecular Aspects of Naxos Disease	2
Imaging in Hypertrophic Cardiomyopathy: Beyond Risk Stratification	2
Novel Approaches to Sleep Apnea in Heart Failure	2
Copyright	2
Translational Cardio-Oncology Research to Promote Better Outcomes for One and All	2
Challenges in Pulmonary Hypertension	1
SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction	1
Obesity in Heart Failure with Reduced Ejection Fraction	1
How to Start an Invasive Cardiopulmonary Exercise Testing Program	1
Translational Research in Cardio-Oncology	1
Valvular Heart Failure due to Tricuspid Regurgitation	1
Contents	1
Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease	1
Congestion in Patients with Advanced Heart Failure	1
Novel PET Applications and Radiotracers for Imaging Cardiovascular Pathophysiology	1
Monitoring for Valve Decrepitude: Surveillance Echo for All at Age 60…?	1
Use and Prognostic Implications of Cardiac Troponin in COVID-19	1
Copyright	1
Forthcoming Issues	1
Left Ventricular Assist Device	1
Contributors	1
Contributors	1
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19	1
Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies	1
Radionuclide Imaging of Infective Endocarditis	1
Cardiac PET Imaging for Coronary Artery Disease and Heart Failure	1
Challenges in Pulmonary Hypertension	1
Contributors	1
Copyright	1
SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction	1
Radionuclide Assessment of Sarcoidosis	1
Using Artificial Intelligence to Better Predict and Develop Biomarkers	1
Nuclear Cardiology	1
Heart Failure Preserved Ejection Fraction in Women	0
Renoprotective Effects of SGLT2 Inhibitors	0
Forthcoming Issues	0
Interventional Approaches to Augment Pharmacotherapy in Heart Failure	0
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia	0
Training and Career Development in Cardio-Oncology Translational and Implementation Science	0
Digital Health	0
Pregnancy and Pulmonary Hypertension	0
Forthcoming Issues	0
The Influence of Genotype on the Phenotype, Clinical Course, and Risk of Adverse Events in Children with Hypertrophic Cardiomyopathy	0
Primary Mitral Regurgitation and Heart Failure	0
Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management	0
Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects	0
Contributors	0
Oxygen Therapy in Pulmonary Vascular Disease	0
Advanced Heart Failure	0
Hypertrophic Cardiomyopathy in RASopathies	0
Microscopic Examination of Clots from Percutaneous Mechanical Embolectomies in Pulmonary Embolism	0

Exercise Testing in Elite Athletes	0
Contents	0
Failing with Cyanosis-Heart Failure in End-Stage Unrepaired or Partially Palliated Congenital Heart Disease	0
Assessment of Right Ventricle Function and Tricuspid Regurgitation in Heart Failure: Current Advances in Diagnosis and Imaging	0
Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity	0
The War Against Heart Failure Hospitalizations	0
SGLT2 Inhibitors Are Lifesavers in Heart Failure	0
The Emerging Role of Artificial Intelligence in Valvular Heart Disease	0
Interatrial Shunt Devices	0
The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy	0
Cardiopulmonary Exercise Testing in Research	0
Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care	0
Coronary Artery Disease and Heart Failure—Continued Significant Morbidity and Mortality Highlights Need for Comprehensive Evaluation to Individualize Patient Management	0
Contents	0
Phenotyping the Many Faces of Hypertrophic Cardiomyopathy	0
Advanced Heart Failure in Special Population—Pediatric Age	0
The Arrhythmic Phenotype in Cardiomyopathy	0
Cardiac Amyloidosis	0
Cardiac Amyloidosis	0
Copyright	0
Forthcoming Issues	0
Copyright	0
Forthcoming Issues	0
Copyright	0
Cardiovascular Health Care Implications of the COVID-19 pandemic	0
SGLT-2 Inhibitors	0
Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology	0
PET Imaging for Cardiomyopathy Challenges Simplistic Notions of Ischemia and Viability	0
The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis	0
Copyright	0
Forthcoming Issues	0
Cardiopulmonary Exercise Testing in Pulmonary Hypertension	0
Copyright	0
Cardiovascular Magnetic Resonance in the Management of Cardiac Amyloidosis	0
Targeted Therapies for Microvascular Disease	0
Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension	0
The Economic Burden of Heart Failure with Reduced Ejection Fraction	0
Listing Criteria for Heart Transplant	0
Hypertrophic Cardiomyopathy in the Absence of “Hypertrophy”	0
Contents	0
Contributors	0
Artificial Intelligence and Mechanical Circulatory Support	0
Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction	0
Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction	0
Viability and Congestive Heart Failure	0
Heart Failure with Reduced Ejection Fraction	0
Genetics in Congenital Heart Diseases	0
Palliative Care in Adult Congenital Heart Disease–Associated Advanced Heart Disease	0
Multimodality Imaging in Aortic Stenosis	0
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension	0
Forthcoming Issues	0
Cardioprotection of High-Risk Individuals	0
Heart Failure with Reduced Ejection Fraction and COVID-19, when the Sick Get Sicker	0
Contents	0
Contents	0
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice	0
Cardiovascular Involvement in mtDNA Disease	0
Stress-First Myocardial Perfusion Imaging	0
Contributors	0
Contents	0
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis	0
Utilizing Artificial Intelligence to Enhance Health Equity Among Patients with Heart Failure	0
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis	0
Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus	0
Coronary Artery Disease and Heart Failure	0
Arrhythmic Stratification of Cardiac Amyloidosis	0
Valvular Heart Disease and Heart Failure	0
Tricuspid Regurgitation and Right Heart Failure	0
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events	0
Contents	0
Evaluation of Coronary Artery Disease and Ischemia by Echocardiography	0
Arrhythmogenic Cardiomyopathy	0
Advances in Machine Learning Approaches to Heart Failure with Preserved Ejection Fraction	0
Framework for Digital Health Phenotypes in Heart Failure	0
Left Ventricular Assist Device and the Current State of the Art: HeartMate 3 at 5 Years	0
Cardiovascular Effects of COVID-19	0
The Non-invasive Assessment of the Pulmonary Circulation-Right Ventricular Functional Unit	0
Contributors	0
Cardiac Implantable Electronic Devices in Ischemic Cardiomyopathy	0
Forthcoming Issues	0
Standard Therapy in Cardiac Amyloidosis	0
Secondary Mitral Regurgitation and Heart Failure	0
Contents	0
Extracardiac Prothrombotic Effects of COVID-19	0
Copyright	0
Utilizing Conversational Artificial Intelligence, Voice, and Phonocardiography Analytics in Heart Failure Care	0
Evaluation of Coronary Artery Disease and Ischemia by Cardiac Magnetic Resonance Imaging	0
Forthcoming Issues	0
Clinical Manifestations of 22q11.2 Deletion Syndrome	0
The Ability of Near-Infrared Spectroscopy to Identify Vulnerable Patients and Plaques: A Systematic Review and Meta-Analysis	0
Cardiopulmonary Exercise Testing, Rehabilitation, and Exercise Training in Postpulmonary Embolism	0
Genotype-Phenotype Correlations in ATTR Amyloidosis	0
Covid-19	0
Surgical Considerations in Adult Congenital Heart Disease Heart Failure	0
Obesity Management for Patients with Coronary Artery Disease and Heart Failure	0